Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction

  • Technology appraisal guidance
  • TA52
  • Published: 
Download guidance (PDF)

9 Sources of evidence considered by the committee

The following documentation and opinion were made available to the committee

A. Assessment report prepared by the Liverpool Reviews and Implementation Group, Department of Pharmacology and Therapeutics, University of Liverpool: Early Thrombolysis for the Treatment of Acute Myocardial Infarction, April 2002

B. Manufacturer/sponsor submissions:

  • Aventis Behring

  • Boehringer Ingelheim

  • Roche

C. Professional/specialist and patient/carer group submissions:

  • British Association for Immediate Care

  • British Association for Nursing in Cardiac Care

  • British Heart Foundation

  • Faculty of Accident & Emergency Medicine and British Association of Accident and Emergency Medicine

  • Faculty of Pre-Hospital Care, Royal College of Surgeons, Edinburgh

  • Joint Royal Colleges Ambulance Liaison Committee and Ambulance Service Association

  • Primary Care Cardiovascular Society

  • Royal College of Physicians and British Cardiac Society

  • Warwickshire Health Authority

  • Welsh Ambulance Services NHS Trust

D. Expert perspectives:

  • Professor Douglas Chamberlain, Chairman, Joint Royal Colleges Ambulance Liaison Committee

  • Mr Andrew Marsden, Consultant Medical Director, Scottish Ambulance Service

  • Professor Richard Vincent, Consultant Cardiologist and Professor of Medicine, Trafford Centre for Medical Research